Nanotechnology and Drug Delivery Innovations in Lung Cancer Treatment
- Publisher's listprice GBP 120.00
-
57 330 Ft (54 600 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 11 466 Ft off)
- Discounted price 45 864 Ft (43 680 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
57 330 Ft
Availability
Not yet published.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 1
- Publisher CRC Press
- Date of Publication 27 February 2026
- ISBN 9781032978611
- Binding Hardback
- No. of pages328 pages
- Size 254x178 mm
- Language English
- Illustrations 6 Illustrations, black & white; 25 Illustrations, color; 9 Halftones, color; 6 Line drawings, black & white; 16 Line drawings, color; 23 Tables, black & white 0
Categories
Short description:
This book examines the role of nanotechnology in transforming the diagnosis, treatment, and management of lung cancer.
MoreLong description:
This book examines the role of nanotechnology in transforming the diagnosis, treatment, and management of lung cancer. The initial chapters introduce lung cancer through its epidemiology, pathophysiology, and immunological mechanisms. The subsequent chapters emphasize the role of novel nanoparticles in early detection and imaging of lung cancer. The book then explores the potential of different nanomaterials, such as metal and metal oxide nanoparticles, nano micelles, carbon nanotubes, liposomes, polymeric nanoparticles, solid lipid nanoparticles, dendrimers, nanofibers, and quantum dots, in lung cancer treatment. Each chapter focuses on the unique properties from targeted drug delivery to improved bioavailability and reduced side effects. Exploring theragnostic nanoparticles, the book highlights their dual role in diagnosis and therapy, alongside nano-immunotherapy strategies for improved cancer treatment.
The book concludes with a critical review of ongoing clinical trials, offering insights into the future of nanotechnology-based lung cancer therapies and emerging trends in the field.
1) Details the epidemiology and pathophysiology of lung cancer, covering disease prevalence, risk factors, and cellular mechanisms.
2) Examines the diagnostic capabilities of nanotechnology, emphasizing the use of nanoparticles in early detection and imaging.
3) Explores the therapeutic potential of various nanomaterials, such as liposomes, dendrimers, and quantum dots, for enhanced drug delivery and treatment.
4) Highlights theranostic nanoparticles, combining diagnostic and therapeutic functions for personalized cancer care.
5) Reviews clinical trials and emerging trends, providing insights into the future of nanotechnology-based lung cancer therapies
The book is intended for researchers of oncology, nanomedicine, pharmaceutical sciences, and biomedical engineering.
MoreTable of Contents:
Chapter 1: Introduction to LUNG CANCER. Chapter 2:Epidemiology and Pathophysiology of LUNG CANCER. Chapter 3: Immunology of LUNG CANCER. Chapter 4: Nanotechnology in the Diagnosis of LUNG CANCER. Chapter 5: Metal and Metal Oxide Nanoparticles for the Management of LUNG CANCER. Chapter 6: Nanomicelles for the Management of LUNG CANCER. Chapter 7: Carbon Nanotubes for the Management of LUNG CANCER. Chapter 8: Liposomes for the Management of LUNG CANCER. Chapter 9: Polymeric Nanoparticles for the Management of LUNG CANCER.Chapter 10: Solid Lipid Nanoparticles for the Management of LUNG CANCER. Chapter 11: Dendrimers for the Management of LUNG CANCER. Chapter 12: Nanofibers for the Management of LUNG CANCER. Chapter 13: Quantum Dots for the Management of LUNG CANCER. Chapter 14: Theranostic Nanoparticles for the Management of LUNG CANCER. Chapter 15: Nano-immunotherapy for the Management of LUNG CANCER. Chapter 16: Green Nanotechnology for the Management of LUNG CANCER. Chapter 17: Clinical Trials of Drug Delivery Systems for the Management of LUNG CANCER.Chapter 18: Future Directions in the Management of LUNG CANCER .Bibliography. Glossary
More
